standard open technique. Randomized controlled trials to compare RaPN and OPN have been difficult due to ethical, financial, and time limitations. With the aim to fill this gap, we performed the update meta-analysis of comparative perioperative, functional, and oncologic outcomes for RaPN and OPN.
| METHOD AND MATERIALS
The current meta-analysis that was conducted under rigorous guidelines as described in the preferred reporting items for systematic reviews and meta-analyses (PRISMA) recommendations (Figure 1 ). 12 
| Database searches and identification of eligible papers
A systematic literature review was performed by using PubMed, Embase, ClinicalKey, Cochrane Library, ProQuest, ScienceDirect, Web of Science, and ClinicalTrials.gov to April 11, 2018 , with keyword of (open partial nephrectomy) AND (robotic assisted partial nephrectomy OR robotic partial nephrectomy). To include as many eligible articles as possible, we did not set any limitation term during literature search strategy except for only limitation of language of English written. To expand the potentially eligible articles, we searched for articles from the reference lists of specific review and original articles relevant to current topic. 
| Assessment of study quality
The quality of enrolled studies was determined using the NewcastleOttawa scale (NOS) (www.ohri.ca/programs/clinical_epidemiology/ oxford.asp). A NOS score of 5 or less was considered low, 6 to 7 was intermediate, and 8 to 9, high quality. The level of evidence of each study was also rated.
| Data analysis
Two independent authors reviewed the full texts of the included studies. Patient baseline demographics (age, sex, body mass index What is already known about this subject?
• Traditional open partial nephrectomy (OPN) has been the standard approach for larger and more complex renal tumors.
• Evolution of minimal invasive techniques led to the adoption of robotic-assisted partial nephrectomy (RaPN).
• Previous observational studies showed that RaPN is also feasible in dealing with large, complex, and hilar renal masses.
What are the new findings?
• Compared with OPN, RaPN carried the advantage not only of decreased blood loss, less blood transfusion, lower postoperative complication rate, and shorter length of hospital stay but also lower readmission rate and less eGFR decline.
• The superiority of RaPN in estimated blood loss was attenuated with highly complex renal masses (RENAL score > 9).
• The superiority of RaPN in intraoperative complication rate was strengthened with renal hilar control.
• The advantage of RaPN in positive surgical margin was increased in patient with BMI < 28.
How might these results change the focus of research or clinical practice? Random-effects meta-analysis models were applied with the Comprehensive Meta-Analysis software, version 3 (Biostat, Englewood, New Jersey) for the presumed heterogeneity among the recruited studies. 15 Effect sizes (ESs) of the analyses were investigated by odds ratio (OR) for binary data and Hedges' g for continuous data.
The Cochrane Q statistic and I 2 statistic were used for evaluating heterogeneity among studies. 16, 17 Funnel plots 18 and Egger's regression analysis 19 were used to assess publication bias. Besides, Duval and Tweedie's trim and fill test was used to adjust the ESs for data with significant publication bias. 20 The one study removal method for detecting outliers was used for sensitivity analyses. 21 Meta-regression and/or subgroup analysis was used in datasets over five articles to assess for potential sources of heterogeneity among extracted variables including age, sex, BMI, ASA score, tumor size, RENAL nephrometry score, 22 and renal hilar control status.
Two-tailed tests were used for all comparisons and a P value of <0.05 was considered statistically significant. The present meta-analysis of a large-pooled sample revealed that RaPN had decreased blood loss, blood transfusion, postoperative complication rate, and length of stay (LOS) when compared with OPN. No difference was noted with ischemic time, conversion rate, PSM, and recurrence rate. RaPN had decreased readmission rate and a favorable postoperative eGFR impact.
Wu et al, 13 Shen et al, 56 and Xia et al 57 between studies, random-effect model was applied for our analyses.
Meta-regression analyses and sensitivity tests were used to clarify the impact of possible confounding factors for heterogeneity and the outliers of studies to achieve updated and comprehensive analyses.
Decreased EBL was found in RaPN group rather than OPN in the present meta-analysis, consistent with prior literatures. 56, 57 With wide application of robotic platform, RaPN even had a decreased EBL for complex renal masses such as endophytic and hilar ones. 34, 52 However, our meta-regression analysis revealed that when tumor complexity highly increased (RENAL score ≥ 9), the advantage of RaPN in terms of EBL was significant reduced, confirming results for renal mass over 7 cm was reported by Malkoc et al. 47 Accordingly, RaPN associ- 
| Limitation
Our analysis has a number of limitations. First, the majority of studies were retrospective, nonrandomized comparisons, except two prospectively derived studies. Second, there was significant variation for EBL, transfusion rate, intraoperative complications, operative time, PSM, recurrence rates, and hospital stay. Although conducting metaregression and subgroup analyses to identify confounding factors and outlier studies for heterogeneities, other factors such size of series, surgeon experience, varied approaches of renal hilar control, and varied methods for measuring clinical variables still contribute to the study heterogeneity. Third, there was publication bias in regard with EBL, postoperative complication rate, hospital stay, PSM, and readmission rates. Trim and fill test only revealed significant change on readmission rate; readmission rate was strongly influenced by publication bias. Finally, most studies reported insufficient and varied follow-up period, and thus our pooled analyses evaluating long-term oncologic and functional outcomes were limited.
| CONCLUSION
This meta-analysis showed that compared with OPN, RaPN is associated with decreased blood loss, blood transfusion and complication rates, longer operative time, shorter hospital stay, lower readmission rate, and minor eGFR change. Some advantages of RaPN was strengthen in nonobese patients and/or with renal hilar control but attenuated in patients with highly complex renal tumor. However, these results should be applied with caution in clinical practice due to suboptimal quality of evidence and study heterogeneity. Further prospective randomized clinical studies with adequate follow-up is needed not only to validate our results but also to establish robust safety and efficacy evidence of robotic renal surgery.
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